
GamaMabs Pharma to present updated results at 2019 ASCO Annual Meeting from the First-In-Human clinical study of murlentamab in advanced gynecological cancers

Ophthalmology: Horus Pharma distributes ILUVIEN® in France

Robocath strengthens its medical advisory board with international interventional cardiology experts

Bionure appoints Dr. Lucia Septien as chief medical offer

TreeFrog Therapeutics raises over €7M ($7.8M) in Series A financing round 6 months after incorporation

Provepharm Life Solutions receives €42M

Neuroprotection Biotech Bionure Reports Successful Phase 1 Study for Lead Candidate BN201

PDC*line Pharma obtains authorization to launch phase I/II trial of its cancer vaccine (PDC*lung01) in non-small cell lung cancer
